ACRO released a new analytical report on the takeaways from our 2020 landscape survey of RBM and RBQM implementation.
ACRO Chair and Executive Industry Advisor at Medidata, Jackie Kent, BS, authored an Op-Ed for MedPage Today on how broader representation can help address health disparities and improve patient outcomes.
Click here for ACRO’s latest statements on the COVID-19 pandemic.
Read about ACRO’s initiatives, COVID-19 efforts, and more.
Take a look at how our members are innovating in top focus areas.
The efficacy of #ClinicalTrials can be vastly improved by boosting participant diversity. A recent survey found that including Spanish-speaking research personnel increases interest in joining studies among the #Latino community. Read more: https://bit.ly/3SSWhns
The act of connecting real-world #data and registration trials holds the promise of swiftly pushing forward drug approvals for complex and serious conditions. Learn more about the many benefits and possibilities. https://bit.ly/3AzRqkh
Tailored strategies can optimize stakeholder communications and decision-maker engagement, but a nuanced understanding is critical. Watch the @ICONplc webinar on #healthcare decision-maker preferences around product information for more details: https://bit.ly/3AzRJeV
Get ACRO’s newsletter to stay informed about our work and the industry.
The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…
Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…
The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…
Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…
Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
';